Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer

Nataniel H. Lester-Coll, Joan Skelly, Pamela M. Vacek, Brian L. Sprague

Open source

DOI
10.21037/jtd-21-1835
Published
2022-07
Container
Journal of Thoracic Disease
Publisher
AME Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/jtd-21-1835,
  title = {Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer},
  author = {Nataniel H. Lester-Coll and Joan Skelly and Pamela M. Vacek and Brian L. Sprague},
  year = {2022},
  journal = {Journal of Thoracic Disease},
  doi = {10.21037/jtd-21-1835},
  url = {https://doi.org/10.21037/jtd-21-1835}
}

RIS

TY  - JOUR
TI  - Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer
AU  - Nataniel H. Lester-Coll
AU  - Joan Skelly
AU  - Pamela M. Vacek
AU  - Brian L. Sprague
PY  - 2022
JO  - Journal of Thoracic Disease
DO  - 10.21037/jtd-21-1835
UR  - https://doi.org/10.21037/jtd-21-1835
ER  - 

APA

Lester-Coll, N. H., Skelly, J., Vacek, P. M., & Sprague, B. L. (2022). Trends and costs of stereotactic body radiation therapy in metastatic non-small cell lung cancer. Journal of Thoracic Disease. https://doi.org/10.21037/jtd-21-1835

Source records